Use of HMGB proteins and nucleic acids that code therefor

Details for Australian Patent Application No. 2002358771 (hide)

Owner Alcedo Biotech GmbH

Inventors Bullerdiek, Jorn

Agent Pizzeys

Pub. Number AU-B-2002358771

PCT Number PCT/EP02/14579

PCT Pub. Number WO2003/051383

Priority 101 62 556.1 19.12.01 DE

Filing date 19 December 2002

Wipo publication date 30 June 2003

Acceptance publication date 23 April 2009

International Classifications

G01N 33/531 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Production of immunochemical test materials

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/711 (2006.01) - Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 15/08 (2006.01) Drugs for genital or sexual disorders

A61P 15/18 (2006.01) Drugs for genital or sexual disorders

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 101 62 556.1 19.12.01 DE

28 August 2003 Application Open to Public Inspection

  Published as AU-B-2002358771

23 April 2009 Application Accepted

  Published as AU-B-2002358771

23 July 2009 Application for Amendment

  The nature of the amendment is: Amend the name of the inventor from Bullerdiek, Jorn to Bullerdiek, Joern. Address for service in Australia - Pizzeys Level 2, Woden Plaza Offices Woden Town Square Woden ACT 2606 2003

23 July 2009 Alteration of Name

  The name of the applicant has been altered to alcedo biotech GmbH 2003

12 November 2009 Amendment Made

  The nature of the amendment is: Amend the name of the inventor from Bullerdiek, Jorn to Bullerdiek, Joern

19 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002358772-Pyrrolidine derivatives as prostaglandin modulators

2002358770-HUMAN CELLULAR PROTEIN KINASES, METALLOPROTEASES AND PHOSPHATASES AS TARGETS FOR MEDICAL INTERVENTION AGAINST HEPATITIS C VIRUS INFECTIONS